Parkinson’s disease: Neurotransmitter and neurotoxin receptors and their genes

George R. Uhl

Research output: Contribution to journalArticlepeer-review

21 Scopus citations


Studies of the changes in brain neurotransmitter and neurotoxin receptors in Parkinson’s disease now provide information about the state of many receptors. The status of dopamine receptors in the striatum, the possibility that specific neurotoxin receptors exist and the likelihood that receptors in other brain regions, including pathologically involved substantia nigra and cerebral cortex, can provide meaningful information about brain function and the disease are reviewed. Increasing information about these receptors is also available from molecular biological studies of dopamine receptors, and of genes encoding several of the putative candidate sites for possible neurotoxin action. Such approaches are providing an increasingly important perspective on Parkinson’s disease therapeutics and possible pathogenesis.

Original languageEnglish (US)
Pages (from-to)21-30
Number of pages10
JournalEuropean Neurology
StatePublished - 1990


  • Dopamine transporter
  • MPTP
  • Neurotransmitter receptor
  • Receptor autoradiography
  • Xenopus oocyte

ASJC Scopus subject areas

  • Clinical Neurology
  • Neurology


Dive into the research topics of 'Parkinson’s disease: Neurotransmitter and neurotoxin receptors and their genes'. Together they form a unique fingerprint.

Cite this